Arcus Biosciences, Inc. Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Letter Agreement, dated July 25, 2022, between the Registrant and Dimitry S.A. Nuyten, MD., Ph.D (Filed With SEC on November 2, 2022)
- Letter Agreement with Gilead Sciences, Inc. dated July 1, 2022 (Filed With SEC on August 3, 2022)
- Arcus Biosciences, Inc. Amended and Restated 2020 Inducement Plan (Filed With SEC on February 23, 2022)
- Arcus Biosciences, Inc. Amended and Restated 2020 Inducement Plan (Filed With SEC on February 25, 2021)
- Dated November 10, 2020 Arcus Biosciences, Inc. WuXi Biologics (Cayman) Inc. and WuXi Biologics Ireland Limited (Filed With SEC on February 25, 2021)
- Offer letter by and between Arcus Biosciences, Inc. and Robert C. Goeltz II dated June 30, 2020 (Filed With SEC on November 5, 2020)
- Offer letter by and between Arcus Biosciences, Inc. and Jennifer Jarrett dated September 10, 2020 (Filed With SEC on November 5, 2020)
- Arcus Biosciences, Inc. 2020 Inducement Plan (Filed With SEC on March 5, 2020)
- Offer Letter, dated May 20, 2019, between the Company and Jason Barker (Filed With SEC on November 5, 2019)
- Offer Letter, dated March 16, 2019, between the Company and William Grossman (Filed With SEC on August 6, 2019)
- Offer Letter, dated February 22, 2019, between the Company and Rekha Hemrajani (Filed With SEC on May 2, 2019)
- Amended and Restated Letter Agreement, dated February 14, 2018, between the Registrant and Terry Rosen, Ph.D (Filed With SEC on February 16, 2018)
- Amended and Restated Letter Agreement, dated February 14, 2018, between the Registrant and Juan Carlos Jaen, Ph.D (Filed With SEC on February 16, 2018)
- Amended and Restated Letter Agreement, dated February 14, 2018, between the Registrant and Jennifer Jarrett (Filed With SEC on February 16, 2018)
